Selected article for: "cell line and Env pol"

Author: Zhang, XiZhen; Wang, XiaoDan; Zhao, DongHai; Meng, XiangYu; Zhao, XingHong; Yu, XiangHui; Kong, Wei
Title: Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
  • Document date: 2011_12_16
  • ID: xxypq3wd_3
    Snippet: VLPs are now considered one of the most attractive candidate vaccines for HIV and multiple VLP-based vaccines for HIV-1 are currently under investigation [12, [17] [18] [19] [20] [21] [22] . However, it is still generally desirable to enhance VLP immunogenicity. In this study, we report the construction of VLPs by cotransfecting two kinds of plasmids into HEK293 cells to obtain a mammalian cell line that efficiently and stably expresses the HIV-1.....
    Document: VLPs are now considered one of the most attractive candidate vaccines for HIV and multiple VLP-based vaccines for HIV-1 are currently under investigation [12, [17] [18] [19] [20] [21] [22] . However, it is still generally desirable to enhance VLP immunogenicity. In this study, we report the construction of VLPs by cotransfecting two kinds of plasmids into HEK293 cells to obtain a mammalian cell line that efficiently and stably expresses the HIV-1 structural proteins Gag, pol, and Env. The VLPs induce specific humoral and cellular immune responses after immunization, without any adjuvant.

    Search related documents:
    Co phrase search for related documents
    • candidate vaccine and cellular humoral immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • candidate vaccine and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • candidate vaccine and specific cellular humoral immune response: 1, 2
    • candidate vaccine and specific cellular humoral immune response induce: 1
    • candidate vaccine and structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • candidate vaccine and VLP base: 1
    • candidate vaccine and VLP base vaccine: 1
    • candidate vaccine and VLP immunogenicity: 1, 2, 3, 4
    • cell line and Env pol: 1, 2
    • cell line and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell line and plasmid kind: 1
    • cell line and specific cellular humoral immune response: 1, 2
    • cell line and structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • cellular humoral immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cellular humoral immune response and specific cellular humoral immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • cellular humoral immune response and specific cellular humoral immune response induce: 1
    • Env pol and immune response: 1
    • immune response and structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and VLP immunogenicity: 1